473269-70-4 Usage
Uses
Used in Cosmetic Industry:
4-tert-Butyl-2,6-diaminoanisole is used as a hair dye ingredient for its efficient oxidation and coupling abilities, which contribute to the coloration and stability of hair dyes. Its complex chemical structure allows for versatile applications in hair color products, enhancing their performance and effectiveness.
Used in Hair Dye Products:
4-tert-Butyl-2,6-diaminoanisole is used as a key component in hair dye formulations for its ability to facilitate the oxidation and coupling processes that are essential for achieving the desired hair color. Its presence in these products helps to ensure a long-lasting and vibrant color result.
However, it is important to note that due to its potential health risks, such as skin sensitization and eye and skin irritation, 4-tert-Butyl-2,6-diaminoanisole should always be used under proper safety precautions to minimize the risk of adverse effects. This may include the use of protective gloves, eye protection, and ensuring adequate ventilation during application. Additionally, it is crucial to follow the manufacturer's instructions and guidelines for safe use and handling of products containing 4-tert-Butyl-2,6-diaminoanisole.
Check Digit Verification of cas no
The CAS Registry Mumber 473269-70-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,7,3,2,6 and 9 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 473269-70:
(8*4)+(7*7)+(6*3)+(5*2)+(4*6)+(3*9)+(2*7)+(1*0)=174
174 % 10 = 4
So 473269-70-4 is a valid CAS Registry Number.
InChI:InChI=1/C11H18N2O/c1-11(2,3)7-5-8(12)10(14-4)9(13)6-7/h5-6H,12-13H2,1-4H3
473269-70-4Relevant articles and documents
7-(Piperazine-1-Ymethyl)-1H-Indole-2-Carboxylic Acid (Phenyl)-Amide Derivatives and Allied Compounds as P38 Map Kinase Inhibitors for the Treatment of Respiratory Diseases
-
Page/Page column 55, (2011/11/12)
The present invention provides compounds according to general formula (I) which are proposed for the treatment of respiratory complaints, particularly asthma and COPD.
Discovery and optimization of p38 inhibitors via computer-assisted drug design
Goldberg, Daniel R.,Hao, Ming-Hong,Qian, Kevin C.,Swinamer, Alan D.,Gao, Donghong A.,Xiong, Zhaoming,Sarko, Chris,Berry, Angela,Lord, John,Magolda, Ronald L.,Fadra, Tazmeen,Kroe, Rachel R.,Kukulka, Alison,Madwed, Jeffrey B.,Martin, Leslie,Pargellis, Christopher,Skow, Donna,Song, Jinhua J.,Tan, Zhulin,Torcellini, Carol A.,Zimmitti, Clare S.,Yee, Nathan K.,Moss, Neil
, p. 4016 - 4026 (2008/02/12)
Integration of computational methods, X-ray crystallography, and structure-activity relationships will be disclosed, which lead to a new class of p38 inhibitors that bind to p38 MAP kinase in a Phe out conformation.
Bis-Amination of Aryl Halides
-
Page/Page column 4, (2008/06/13)
Disclosed are methods for making 1,3- and 1,4-diamino-phenyl intermediates by utilizing bis-amination of ortho-substituted aryl halides.
1,4-Disubstituted benzo-fused compounds
-
, (2008/06/13)
Disclosed are novel 1,4-disubstituted benzo-fused compounds wherein G, X, L, Q, n and Y are defined herein. The compounds are useful in pharmaceutic compositions for treating diseases or pathological conditions involving inflammation such as chronic infla